(Q43294410)

English

The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use.

scientific article published on 11 August 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1 reference

based on heuristic

inferred from title

4

object named as

Malte Kelm

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Rainer Hoffmann

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Helene Klinker

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Umar Adamu

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Rüdiger Blindt

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

11 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Clinical Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

549-554

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug eluting stents are safe for licensed indications, FDA panel says

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes and complications associated with off-label and untested use of drug-eluting stents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stent thrombosis redux--the FDA perspective.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19669824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-009-0039-8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43294410&oldid=2205945243"